← Leaderboards
Joshua Reynolds
Atlas Biologics, Llc
$1,455,000
Attributed
$1,455,000
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$1,455,000 · 2
By mechanism
R44$1,000,000 · 1
R42$455,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Frequencies”
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
- Jinsy Andrews · Columbia University Health Sciences$11,474,975
- Nancy Jean Sullivan · Boston University Medical Campus$7,541,758
- Jacob Sutton Coverstone · Neurovations$6,882,205
- Jennifer Lapek · Scripps Institution Of Oceanography$6,359,752
Research focus
FrequenciesInhibitorDrug TargetingEvolutionGrantIndustryDrug DesignDrug EvaluationEffective TherapyAccelerationAnti-CancerCause Of DeathBcr-Abl Fusion ProteinsCellsAntineoplastic AgentsDesignBusinessesDrug DevelopmentClinical TrialsCancer PatientCommercializationComplexCancer TypeLead Candidate
Grant awards (3)
Development of Deep Mutational Scanning with Duplex Sequencing (DMS-DS) for anti-cancer drug evaluation and administration$1,000,000
R44 · FY2025 · CA · contact PI
Development of Deep Mutational Scanning with Duplex Sequencing (DMS-DS) for anti-cancer drug evaluation and administration$400,000
R42 · FY2024 · CA · contact PI
Development of Deep Mutational Scanning with Duplex Sequencing (DMS-DS) for anti-cancer drug evaluation and administration$55,000
R42 · FY2024 · CA · contact PI